Skip to Content

93 154 (Ticlopidine 250 mg)

Pill with imprint 93 154 is White, Elliptical / Oval and has been identified as Ticlopidine hydrochloride 250 mg. It is supplied by Teva Pharmaceuticals USA.

Ticlopidine is used in the treatment of cerebral thrombosis/embolism and belongs to the drug class platelet aggregation inhibitors. There is no proven risk in humans during pregnancy. Ticlopidine 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 93 154

Ticlopidine hydrochloride 250 mg 93 154 Front
Ticlopidine hydrochloride 250 mg 93 154 Back
Ticlopidine hydrochloride 250 mg 93 154
Ticlopidine hydrochloride 250 mg 93 154

Ticlopidine hydrochloride

93 154
250 mg
15.00 mm
Elliptical / Oval
Prescription only
Drug Class:
Platelet aggregation inhibitors
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Teva Pharmaceuticals USA
Inactive Ingredients:
butylated hydroxyanisole
corn starch
magnesium stearate
microcrystalline cellulose
polyethylene glycol
stearic acid
titanium dioxide
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
42291-0803 AvKare, Inc.

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.